Related Experiment Video
Updated: Jul 13, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Staphylococci
A L Casey1, P A Lambert, T S J Elliott
1Department of Clinical Microbiology and Infection Control, University Hospital Birmingham NHS Foundation Trust, The Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.
Abstract:
Staphylococci are among the leading causes of nosocomial infections. Increasing insusceptibility to beta-lactams and the glycopeptides complicates treatment of these infections. This review examines the current status and future perspectives for the therapy of infections caused by Staphylococcus aureus and coagulase-negative staphylococci.
Insights
Staphylococci cause many hospital infections, and resistance to common antibiotics like beta-lactams and glycopeptides is increasing. This review discusses current and future Staphylococcus treatment options.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Staphylococci are a major cause of nosocomial infections.
- Increasing antimicrobial resistance to beta-lactams and glycopeptides complicates treatment.
- Effective therapeutic strategies are crucial for managing staphylococcal infections.
Purpose of the Study:
- To review the current therapeutic landscape for staphylococcal infections.
- To explore future perspectives in the treatment of Staphylococcus aureus and coagulase-negative staphylococci infections.
- To address the challenge of antimicrobial resistance in staphylococci.
Main Methods:
- Literature review of current research and clinical studies.
- Analysis of antimicrobial susceptibility patterns.
- Evaluation of existing and emerging therapeutic agents.
- Discussion of treatment guidelines and challenges.
Main Results:
- Staphylococcal infections remain a significant clinical challenge.
- Resistance to beta-lactams and glycopeptides is a growing concern.
- A variety of therapeutic options exist, but novel approaches are needed.
- Emerging therapies show promise for combating resistant strains.
Conclusions:
- Effective management of staphylococcal infections requires a multifaceted approach.
- Continued research into new antimicrobial agents and treatment strategies is essential.
- Addressing antimicrobial resistance is critical for improving patient outcomes.
Related Concept Videos
Staphylococcal Skin Infections
Bacterial Phylum Actinobacteria
Bacterial Phylum Spirochaetes
Bacterial Phylum Bacteroidota
Special Staining Techniques
Bacterial Phylum Firmicutes